World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
84
Citations
26664
World Ranking
15060
National Ranking
191

Marianne Paesmans publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Marianne Paesmans sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 663 publications — 78th percentile

78% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Marianne Paesmans D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Marianne Paesmans sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 84 D-Index — 27th percentile

27% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Marianne Paesmans is affiliated with the Université Libre de Bruxelles in Belgium. Their research primarily falls within the broad field of Medicine, with significant contributions in multiple subfields including Oncology, Pulmonary and Respiratory Medicine, Surgery, Cancer Research, and Orthopedics and Sports Medicine.

The scientist's work focuses on several main topics, among which are:

  • Advanced Breast Cancer Therapies
  • Bone health and osteoporosis research
  • Breast Cancer Treatment Studies
  • HER2/EGFR in Cancer Research
  • Hip and Femur Fractures
  • Cancer Treatment and Pharmacology
  • Cancer Immunotherapy and Biomarkers

Marianne Paesmans has contributed to a number of publications in well-recognized venues. Frequent publication venues include:

  • Annals of Oncology
  • Journal of Clinical Oncology
  • Bone Reports
  • npj Breast Cancer
  • Cancer Research

Their recent papers feature a range of clinical and translational oncology studies, such as:

  • Regorafenib after failure of gemcitabine and platinum-based chemotherapy for locally advanced/metastatic biliary tumors: REACHIN, a randomized, double-blind, phase II trial (2020, Annals of Oncology)
  • Pregnancy After Breast Cancer in Patients With Germline BRCA Mutations (2020, Journal of Clinical Oncology)
  • Trastuzumab emtansine (T-DM1)-associated cardiotoxicity: Pooled analysis in advanced HER2-positive breast cancer (2020, European Journal of Cancer)
  • Empiric vs Preemptive Antifungal Strategy in High-Risk Neutropenic Patients on Fluconazole Prophylaxis: A Randomized Trial of the European Organization for Research and Treatment of Cancer (2022, Clinical Infectious Diseases)
  • Pregnancy After Breast Cancer in Young BRCA Carriers (2023, JAMA)

Collaboration networks reveal a series of frequent co-authors who have worked extensively with Paesmans, including:

  • Lieveke Ameye
  • Martine Piccart
  • Evandro de Azambuja
  • Michail Ignatiadis
  • Michel Moreau

The breadth of Paesmans's work reflects an integration of clinical oncology, cancer pharmacology, and supportive care, evidenced by thematic concentration in cancer therapy development, bone-related complications, and biomarkers in immunotherapy. The publication history and coauthorship patterns point to sustained engagement with multidisciplinary teams in oncology and related medical specialties.

Best Publications

  • The Multinational Association for Supportive Care in Cancer Risk Index: A Multinational Scoring System for Identifying Low-Risk Febrile Neutropenic Cancer Patients

    Jean Klastersky;Marianne Paesmans;Edward B. Rubenstein;Michael Boyer

  • Ki-67 as prognostic marker in early breast cancer: a meta-analysis of published studies involving 12,155 patients.

    E de Azambuja;F Cardoso;G de Castro;M Colozza

  • The role of RAS oncogene in survival of patients with lung cancer: a systematic review of the literature with meta-analysis

    Céline Mascaux;N Iannino;Benoît Martin;Marianne Paesmans

  • Cisplatin- Versus Carboplatin-Based Chemotherapy in First-Line Treatment of Advanced Non–Small-Cell Lung Cancer: An Individual Patient Data Meta-analysis

    Andrea Ardizzoni;Luca Boni;Marcello Tiseo;Frank V. Fossella

  • Primary Tumor Standardized Uptake Value (SUVmax) Measured on Fluorodeoxyglucose Positron Emission Tomography (FDG-PET) is of Prognostic Value for Survival in Non-small Cell Lung Cancer (NSCLC): A Systematic Review and Meta-Analysis (MA) by the European Lung Cancer Working Party for the IASLC Lung Cancer Staging Project

    Thierry Berghmans;Michèle Dusart;Marianne Paesmans;Claude Hossein-Foucher

  • Role of p53 as a prognostic factor for survival in lung cancer: a systematic review of the literature with a meta-analysis.

    E. Steels;M. Paesmans;T. Berghmans;F. Branle

  • Prognostic factors for survival in advanced non-small-cell lung cancer: univariate and multivariate analyses including recursive partitioning and amalgamation algorithms in 1,052 patients. The European Lung Cancer Working Party.

    M Paesmans;J P Sculier;P Libert;G Bureau

  • Phase III trial comparing protracted intravenous fluorouracil infusion alone or with yttrium-90 resin microspheres radioembolization for liver-limited metastatic colorectal cancer refractory to standard chemotherapy.

    Alain Hendlisz;Marc Van Den Eynde;Marc Peeters;Geert Maleux

  • Oral versus Intravenous Empirical Antimicrobial Therapy for Fever in Patients with Granulocytopenia Who Are Receiving Cancer Chemotherapy

    W V Kern;A Cometta;R De Bock;J Langenaeken

  • Bacteraemia in febrile neutropenic cancer patients

    Jean Klastersky;Lieveke Ameye;J. Maertens;Aspasia Georgala

  • HER-2 Amplification and Topoisomerase IIα Gene Aberrations as Predictive Markers in Node-positive Breast Cancer Patients Randomly Treated Either with an Anthracycline-based Therapy or with Cyclophosphamide, Methotrexate, and 5-Fluorouracil

    Angelo Di Leo;David Gancberg;Denis Larsimont;Minna Tanner

  • Comparison of HER-2 status between primary breast cancer and corresponding distant metastatic sites

    D. Gancberg;A. Di Leo;F. Cardoso;G. Rouas

  • A comparison of outcome from febrile neutropenic episodes in children compared with adults: Results from four EORTC studies

    Ian Hann;Claudio Viscoli;Marianne Paesmans;Harold Gaya

  • The role of EGF-R expression on patient survival in lung cancer: a systematic review with meta-analysis

    Anne-Pascale Meert;Benoît Martin;Philippe Delmotte;Thierry Berghmans

  • Prophylactic cranial irradiation in small cell lung cancer: a systematic review of the literature with meta-analysis

    Anne-Pascale Meert;Marianne Paesmans;Thierry Berghmans;Benoît Martin

  • Ki-67 expression and patients survival in lung cancer: systematic review of the literature with meta-analysis

    Benoit Martin;Marianne Paesmans;Céline Mascaux;Thierry Berghmans

  • Tumor-infiltrating B cells signal functional humoral immune responses in breast cancer

    Soizic Garaud;Laurence Buisseret;Cinzia Solinas;Chunyan Gu-Trantien

  • Primary tumor standardized uptake value measured on fluorodeoxyglucose positron emission tomography is of prognostic value for survival in non-small cell lung cancer: update of a systematic review and meta-analysis by the European Lung Cancer Working Party for the International Association for the Study of Lung Cancer Staging Project.

    Marianne Paesmans;Thierry Berghmans;Michele Dusart;Camillo Garcia

  • The role of microvessel density on the survival of patients with lung cancer: a systematic review of the literature with meta-analysis

    Anne-Pascale Meert;Marianne Paesmans;Benoît Martin;Philippe Delmotte

  • Prognostic factors for patients with small cell lung carcinoma: analysis of a series of 763 patients included in 4 consecutive prospective trials with a minimum follow-up of 5 years.

    Marianne Paesmans;Jean-Paul Sculier;J. Lecomte;Jacques Thiriaux

Frequent Co-Authors

Jean-Paul Sculier
Jean-Paul Sculier Université Libre de Bruxelles
Martine Piccart
Martine Piccart Université Libre de Bruxelles
Denis Larsimont
Denis Larsimont Université Libre de Bruxelles
Christos Sotiriou
Christos Sotiriou Université Libre de Bruxelles
Fatima Cardoso
Fatima Cardoso Champalimaud Foundation
Ahmad Awada
Ahmad Awada Université Libre de Bruxelles
Evandro de Azambuja
Evandro de Azambuja Université Libre de Bruxelles
Jean-Jacques Body
Jean-Jacques Body Université Libre de Bruxelles
Marc Peeters
Marc Peeters University of Antwerp
Angelo Di Leo
Angelo Di Leo Academy for Urban School Leadership

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring careers in healthcare doesn't always mean following the traditional path of becoming a physician. There are several rewarding options available online that offer flexibility and affordability for students aiming to join the medical field.

For those interested in administrative roles, consider researching how much does it cost to become a medical coder. These programs are designed to be cost-effective, offering a rapid pathway into the workforce.

Aspiring nurses can find excellent cheapest online nursing program options to earn their qualifications entirely online.

If you wish to advance your nursing career further, you might explore the cheapest online nurse practitioner programs. These degrees can open doors to higher salaries and greater responsibility in clinical settings.

For those interested in research or academic leadership, accredited online phd nursing programs provide avenues to make a broader impact on healthcare policy and education.

Best Scientists Citing Marianne Paesmans

Trending Scientists

Recently Published Articles